Abstract
The endorphin neuropeptides may have neuroleptic-like effects on dopamine function and may be antischizophrenic. Ten chronic psychotic patients with neuroleptic-induced tardive dyskinesia and parkinsonism received placebo and des-tyrosine-gamma-endorphin (DT gamma E). Drug effects on movement disorders and eye-blinking rates were assessed by blind evaluations of randomly sequenced videotapes made during standardized examinations before and 30, 60, and 120 minutes after each injection and at 24 hours postinjection on days of consecutive treatment. Changes in schizophrenic symptoms were evaluated openly with the schizophrenia subscale of the Comprehensive Psychiatric Rating Scale. There were no significant effects of DT gamma E on any parameter and no side effects. This suggests that DT gamma E, within the tested dose range, does not influence the pathophysiology of neuroleptic-induced dyskinesias or chronic schizophrenia or have neuroleptic properties. However, DT gamma E is well tolerated and should be tested with higher doses during prolonged treatment.
Citations
Jun 1, 1982·Psychiatry Research·H Y MeltzerA Robertson
Apr 1, 1986·Human Immunology·F H ClaasJ J van Rood
Jan 1, 1989·European Archives of Psychiatry and Neurological Sciences·D de Wied, J M van Ree
May 1, 1987·Peptides·T P DavisT L Smith
Nov 6, 1982·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·E Freed
Jan 1, 1990·Pharmacology & Therapeutics·K Gulya
Apr 1, 1986·Acta Psychiatrica Scandinavica·W M VerhoevenJ M van Ree
Jan 1, 1982·Annals of the New York Academy of Sciences·H M EmrichA Herz
Jan 1, 1982·Annals of the New York Academy of Sciences·J MetzH Y Meltzer
Jan 1, 1986·Movement Disorders : Official Journal of the Movement Disorder Society·A WaltersS Fahn
Feb 7, 2018·The Cochrane Database of Systematic Reviews·Hanna BergmanKarla Soares-Weiser
Feb 18, 2012·The Cochrane Database of Systematic Reviews·Adib Essali, Ghassan Ali
May 5, 2000·The Cochrane Database of Systematic Reviews·J J McGrath, K V Soares
Jun 14, 2003·The Cochrane Database of Systematic Reviews·K V Soares-Weiser, C Joy
Jan 1, 1982·Psychopharmacology·S KorsgaardJ Gerlach
Mar 20, 2018·The Cochrane Database of Systematic Reviews·Karla Soares-WeiserHanna Bergman
May 20, 2003·Neurotoxicity Research·David De Wied, Hein O. Sigling